Cargando…

替加环素为基础的联合方案治疗33例泛耐药革兰阴性杆菌感染血液病患者的临床研究

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342703/
https://www.ncbi.nlm.nih.gov/pubmed/26462782
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.09.014
_version_ 1783555576187322368
collection PubMed
description
format Online
Article
Text
id pubmed-7342703
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Editorial office of Chinese Journal of Hematology
record_format MEDLINE/PubMed
spelling pubmed-73427032020-07-16 替加环素为基础的联合方案治疗33例泛耐药革兰阴性杆菌感染血液病患者的临床研究 Zhonghua Xue Ye Xue Za Zhi 短篇论著 Editorial office of Chinese Journal of Hematology 2015-09 /pmc/articles/PMC7342703/ /pubmed/26462782 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.09.014 Text en 2015年版权归中华医学会所有 http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal.
spellingShingle 短篇论著
替加环素为基础的联合方案治疗33例泛耐药革兰阴性杆菌感染血液病患者的临床研究
title 替加环素为基础的联合方案治疗33例泛耐药革兰阴性杆菌感染血液病患者的临床研究
title_full 替加环素为基础的联合方案治疗33例泛耐药革兰阴性杆菌感染血液病患者的临床研究
title_fullStr 替加环素为基础的联合方案治疗33例泛耐药革兰阴性杆菌感染血液病患者的临床研究
title_full_unstemmed 替加环素为基础的联合方案治疗33例泛耐药革兰阴性杆菌感染血液病患者的临床研究
title_short 替加环素为基础的联合方案治疗33例泛耐药革兰阴性杆菌感染血液病患者的临床研究
title_sort 替加环素为基础的联合方案治疗33例泛耐药革兰阴性杆菌感染血液病患者的临床研究
topic 短篇论著
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342703/
https://www.ncbi.nlm.nih.gov/pubmed/26462782
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.09.014
work_keys_str_mv AT tìjiāhuánsùwèijīchǔdeliánhéfāngànzhìliáo33lìfànnàiyàogélányīnxìnggānjūngǎnrǎnxuèyèbìnghuànzhědelínchuángyánjiū
AT tìjiāhuánsùwèijīchǔdeliánhéfāngànzhìliáo33lìfànnàiyàogélányīnxìnggānjūngǎnrǎnxuèyèbìnghuànzhědelínchuángyánjiū
AT tìjiāhuánsùwèijīchǔdeliánhéfāngànzhìliáo33lìfànnàiyàogélányīnxìnggānjūngǎnrǎnxuèyèbìnghuànzhědelínchuángyánjiū
AT tìjiāhuánsùwèijīchǔdeliánhéfāngànzhìliáo33lìfànnàiyàogélányīnxìnggānjūngǎnrǎnxuèyèbìnghuànzhědelínchuángyánjiū
AT tìjiāhuánsùwèijīchǔdeliánhéfāngànzhìliáo33lìfànnàiyàogélányīnxìnggānjūngǎnrǎnxuèyèbìnghuànzhědelínchuángyánjiū
AT tìjiāhuánsùwèijīchǔdeliánhéfāngànzhìliáo33lìfànnàiyàogélányīnxìnggānjūngǎnrǎnxuèyèbìnghuànzhědelínchuángyánjiū
AT tìjiāhuánsùwèijīchǔdeliánhéfāngànzhìliáo33lìfànnàiyàogélányīnxìnggānjūngǎnrǎnxuèyèbìnghuànzhědelínchuángyánjiū
AT tìjiāhuánsùwèijīchǔdeliánhéfāngànzhìliáo33lìfànnàiyàogélányīnxìnggānjūngǎnrǎnxuèyèbìnghuànzhědelínchuángyánjiū
AT tìjiāhuánsùwèijīchǔdeliánhéfāngànzhìliáo33lìfànnàiyàogélányīnxìnggānjūngǎnrǎnxuèyèbìnghuànzhědelínchuángyánjiū